Innovative CAR-T approaches targeting Claudin 18.2 to counteract drug resistance in gastric cancer
{{output}}
Claudins, integral components of tight junctions, have recently emerged as key modulators of drug resistance in gastric cancer. Claudin18.2 is aberrantly expressed in a subset of gastric tumors, where it disrupts epithelial integrity and promotes tumor progres... ...